Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia
- PMID: 9664905
- DOI: 10.1002/(SICI)1096-9896(199804)184:4<396::AID-PATH1259>3.0.CO;2-G
Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia
Abstract
Experimental studies suggest that cyclin D1 is a potential oncogene but in clinical studies of invasive breast cancer, overexpression of cyclin D1 is found to be associated with oestrogen receptor (ER) expression and low histological grade, both markers of good prognosis. Immunohistochemistry has been used to examine the relationship between cyclin D1 expression and differentiation in 36 cases of ductal carcinoma in situ (DCIS) and the interrelationship between expression of cyclin D1, its associated protein product of the retinoblastoma gene (pRb), and ER, in this group of cases. The expression of these markers has also been examined in nine cases of atypical ductal hyperplasia (ADH) and these results have been compared with the levels of expression seen in DCIS. Cyclin D1 overexpression was found in 23/36 (64 per cent) cases of DCIS and, in contrast to invasive carcinoma, there was no relationship with either differentiation or ER expression. The level of pRb expression was significantly associated with cyclin D1 expression (rS = 0.49, P = 0.001) and only two cases (6 per cent) were pRb-negative. There was no association between pRb and differentiation of DCIS or ER status. In contrast to DCIS, only one case of ADH showed overexpression of cyclin D1 (Mann-Whitney U-test, P = 0.02). All cases of ADH were ER-positive and showed moderate pRb staining, similar to that seen in well-differentiated DCIS. These results provide further evidence that overexpression of cyclin D1 plays a role early in carcinogenesis.
Similar articles
-
Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.J Pathol. 1999 Feb;187(3):279-84. doi: 10.1002/(SICI)1096-9896(199902)187:3<279::AID-PATH240>3.0.CO;2-C. J Pathol. 1999. PMID: 10398079
-
Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.Arch Med Res. 2007 Nov;38(8):846-52. doi: 10.1016/j.arcmed.2007.06.004. Epub 2007 Aug 2. Arch Med Res. 2007. PMID: 17923265
-
Oestrogen receptor expression in the normal and pre-cancerous breast.J Pathol. 1999 Jul;188(3):237-44. doi: 10.1002/(SICI)1096-9896(199907)188:3<237::AID-PATH343>3.0.CO;2-8. J Pathol. 1999. PMID: 10419589
-
Immunohistochemical detection and gene amplification of cyclin D1 in mammary infiltrating ductal carcinoma.Mod Pathol. 1996 Jul;9(7):725-30. Mod Pathol. 1996. PMID: 8832554 Review.
-
Cyclin D1 in mammary carcinoma.J Pathol. 1997 Mar;181(3):267-9. doi: 10.1002/(SICI)1096-9896(199703)181:3<267::AID-PATH783>3.0.CO;2-X. J Pathol. 1997. PMID: 9155710 Review.
Cited by
-
Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development.Breast Cancer Res. 2000;2(2):86-90. doi: 10.1186/bcr38. Epub 2000 Jan 28. Breast Cancer Res. 2000. PMID: 11250696 Free PMC article. Review.
-
Silencing of Xeroderma Pigmentosum Group D Gene Promotes Hepatoma Cell Growth by Reducing P53 Expression.Med Sci Monit. 2018 Nov 9;24:8015-8021. doi: 10.12659/MSM.910944. Med Sci Monit. 2018. PMID: 30409962 Free PMC article.
-
Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters.Afr Health Sci. 2019 Jun;19(2):2140-2146. doi: 10.4314/ahs.v19i2.38. Afr Health Sci. 2019. PMID: 31656498 Free PMC article.
-
Immunodetectable cyclin D(1)is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions.Br J Cancer. 2001 Apr 20;84(8):1064-9. doi: 10.1054/bjoc.2001.1705. Br J Cancer. 2001. PMID: 11308255 Free PMC article.
-
Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.Mol Biol Rep. 2011 Nov;38(8):4955-63. doi: 10.1007/s11033-010-0639-4. Epub 2010 Dec 14. Mol Biol Rep. 2011. PMID: 21161398
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials